These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 26549374)
21. Self-expanding stent for complex percutaneous coronary interventions: A real life experience. Pastormerlo LE; Ciardetti M; Coceani M; Trianni G; Ravani M; Vaghetti M; Rizza A; De Caterina A; Berti S; Palmieri C Cardiovasc Revasc Med; 2016; 17(3):186-9. PubMed ID: 26944852 [TBL] [Abstract][Full Text] [Related]
22. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA; JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410 [TBL] [Abstract][Full Text] [Related]
23. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up. Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536 [TBL] [Abstract][Full Text] [Related]
24. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study. Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717 [TBL] [Abstract][Full Text] [Related]
25. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation. Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559 [TBL] [Abstract][Full Text] [Related]
26. Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography. Gutiérrez-Chico JL; Wykrzykowska J; Nüesch E; van Geuns RJ; Koch KT; Koolen JJ; di Mario C; Windecker S; van Es GA; Gobbens P; Jüni P; Regar E; Serruys PW Circ Cardiovasc Interv; 2012 Feb; 5(1):20-9, S1-8. PubMed ID: 22319063 [TBL] [Abstract][Full Text] [Related]
27. Detection of very early stent healing after primary angioplasty: an optical coherence tomographic observational study of chromium cobaltum and first-generation drug-eluting stents. The DETECTIVE study. Prati F; Stazi F; Dutary J; La Manna A; Di Giorgio A; Pawlosky T; Gonzalo N; Di Salvo ME; Imola F; Tamburino C; Albertucci M; Alfonso F Heart; 2011 Nov; 97(22):1841-6. PubMed ID: 21880655 [TBL] [Abstract][Full Text] [Related]
28. Optical Coherence Tomography Guided Percutaneous Coronary Intervention With Nobori Stent Implantation in Patients With Non-ST-Segment-Elevation Myocardial Infarction (OCTACS) Trial: Difference in Strut Coverage and Dynamic Malapposition Patterns at 6 Months. Antonsen L; Thayssen P; Maehara A; Hansen HS; Junker A; Veien KT; Hansen KN; Hougaard M; Mintz GS; Jensen LO Circ Cardiovasc Interv; 2015 Aug; 8(8):e002446. PubMed ID: 26253735 [TBL] [Abstract][Full Text] [Related]
29. Feasibility and repeatability of optical coherence tomography measurements of pre-stent thrombus burden in patients with STEMI treated with primary PCI. Kajander OA; Koistinen LS; Eskola M; Huhtala H; Bhindi R; Niemelä K; Jolly SS; Sheth T; Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):96-107. PubMed ID: 25240168 [TBL] [Abstract][Full Text] [Related]
30. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods. Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737 [TBL] [Abstract][Full Text] [Related]
31. Impact of Culprit Plaque and Atherothrombotic Components on Incomplete Stent Apposition in Patients With ST-Elevation Myocardial Infarction Treated With Everolimus-Eluting Stents - An OCTAVIA Substudy. Bernelli C; Shimamura K; Komukai K; Capodanno D; Saia F; Garbo R; Burzotta F; Sirbu V; Coccato M; Campo G; Vignali L; Yamamoto H; Niccoli G; Ladich E; Biondi-Zoccai G; Guagliumi G Circ J; 2016; 80(4):895-905. PubMed ID: 26853719 [TBL] [Abstract][Full Text] [Related]
32. Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. Steinberg DH; Mintz GS; Mandinov L; Yu A; Ellis SG; Grube E; Dawkins KD; Ormiston J; Turco MA; Stone GW; Weissman NJ JACC Cardiovasc Interv; 2010 May; 3(5):486-94. PubMed ID: 20488404 [TBL] [Abstract][Full Text] [Related]
33. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first. Gutiérrez-Chico JL; van Geuns RJ; Koch KT; Koolen JJ; Duckers H; Regar E; Serruys PW EuroIntervention; 2011 Oct; 7(6):711-22. PubMed ID: 21986329 [TBL] [Abstract][Full Text] [Related]
34. [Frequency and characteristics of incomplete stent apposition during and after sirolimus-eluting stent implantation]. Takeuchi H; Morino Y; Fujibayashi D; Hashida T; Kawamura Y; Tsumuraya N; Okamoto N; Nagaoka M; Ikari Y; Tanabe T J Cardiol; 2007 Aug; 50(2):111-8. PubMed ID: 17802694 [TBL] [Abstract][Full Text] [Related]
37. Rationale and design of the MGuard for acute ST elevation reperfusion MASTER trial. Costa JR; Abizaid A; Dudek D; Silber S; Leon MB; Stone GW Catheter Cardiovasc Interv; 2013 Aug; 82(2):184-90. PubMed ID: 23008177 [TBL] [Abstract][Full Text] [Related]
38. First report on the use of a novel self-expandable stent for treatment of ST elevation myocardial infarction. IJsselmuiden A; Verheye S Catheter Cardiovasc Interv; 2009 Nov; 74(6):850-4. PubMed ID: 19522001 [TBL] [Abstract][Full Text] [Related]
39. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography. Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964 [TBL] [Abstract][Full Text] [Related]
40. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. Kubo T; Imanishi T; Kitabata H; Kuroi A; Ueno S; Yamano T; Tanimoto T; Matsuo Y; Masho T; Takarada S; Tanaka A; Nakamura N; Mizukoshi M; Tomobuchi Y; Akasaka T JACC Cardiovasc Imaging; 2008 Jul; 1(4):475-84. PubMed ID: 19356470 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]